NTRA

#434
Natera, Inc. - Common Stock
221.5 3 USD
+3.45%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
220.19
223.34
Year Range
131.81
256.27
Daily Change
+3.45%
Monthly Change
+12.24%
6 month change
-7.16%
Year Change
+40.65%
Previous Close
214.1 4
Open
220.8 0
Low
220.1 9
High
223.3 4
Volume
591
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 31.73 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-123.45
Price to sales ratio
11.03

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

News